Basiks Sterilisation Concepts Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 26.35%
- Profit Growth -23.85%
- Ebitda -8.78%
- Net Worth 32.11%
- Total Assets 25.21%
About Basiks Sterilisation Concepts
Basiks Sterilisation Concepts Private Limited (BSCPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 September 2006 and has a history of 18 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ashish Paliwal and Atul Paliwal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909DL2006PTC153939
- Company No.
153939
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Sep 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Basiks Sterilisation Concepts Private Limited offer?
Basiks Sterilisation Concepts Private Limited offers a wide range of products and services, including Laboratory & Lab Equipment, Laboratory Consumables.
Who are the key members and board of directors at Basiks Sterilisation Concepts?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Paliwal  | Director | 16-Sep-2006 | Current |
| Atul Paliwal | Director | 27-May-2017 | Current |
Financial Performance of Basiks Sterilisation Concepts.
Basiks Sterilisation Concepts Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.35% increase. The company also saw a substantial fall in profitability, with a 23.85% decrease in profit. The company's net worth Soared by an impressive increase of 32.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Basiks Sterilisation Concepts?
In 2020, Basiks Sterilisation Concepts had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Basiks Sterilisation Concepts?
Unlock and access historical data on people associated with Basiks Sterilisation Concepts, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Basiks Sterilisation Concepts, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Basiks Sterilisation Concepts's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
